Constitutive expression of TNF-related activation-induced cytokine (TRANCE)/receptor activating NF-κB ligand (RANK)-L by rat plasmacytoid dendritic cells

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Anjubault, Thomas ^a,b,e   Martin, Jérôme ^a,b   Hubert, François Xavier ^a,b   Chauvin, Camille ^a,b   Heymann, Dominique ^c,d   Josien, Régis ^a,b,d  

^a Centre National de la Recherche Scientifique   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Universite de Nantes   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; MEMBRANE PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; CD4 ANTIGEN;

ANIMAL CELL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; LYMPHOID ORGAN; MESENTERY LYMPH NODE; MOLECULAR INTERACTION; NONHUMAN; OSTEOCLASTOGENESIS; PLASMACYTOID DENDRITIC CELL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; INNATE IMMUNITY; KINETICS; LEWIS RAT; LYMPH NODE; METABOLISM; OSTEOCLAST; REAL TIME POLYMERASE CHAIN REACTION;

RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD4; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNITY, INNATE; KINETICS; LYMPH NODES; OSTEOCLASTS; RANK LIGAND; RATS; RATS, INBRED LEW; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84863258878     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033713     Document Type: Article

References (39)

1. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Pulendran B, (2004) Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 199: 227-250.
3. Shortman K, Liu YJ, (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2: 151-161.
4. Facchetti F, de Wolf-Peeters C, Mason DY, Pulford K, van den Oord JJ, et al. (1988) Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. The American journal of pathology 133: 15-21.
5. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, et al. (1997) The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185: 1101-1111.
6. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, et al. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
7. Asselin-Paturel C, Trinchieri G, (2005) Production of type I interferons: plasmacytoid dendritic cells and beyond. The Journal of experimental medicine 202: 461-465.
8. Liu YJ, (2005) IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors. Annu Rev Immunol 23: 275-306.
9. Matsui T, Connolly JE, Michnevitz M, Chaussabel D, Yu CI, et al. (2009) CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. Journal of immunology 182: 6815-6823.
10. Schwab N, Zozulya AL, Kieseier BC, Toyka KV, Wiendl H, (2010) An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. Journal of immunology 184: 5368-5374.
11. Yang GX, Lian ZX, Kikuchi K, Liu YJ, Ansari AA, et al. (2005) CD4- plasmacytoid dendritic cells (pDCs) migrate in lymph nodes by CpG inoculation and represent a potent functional subset of pDCs. J Immunol 174: 3197-3203.
12. Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, et al. (2008) CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nature immunology 9: 1253-1260.
13. Theill LE, Boyle WJ, Penninger JM, (2002) RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20: 795-823.
14. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
15. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95: 3597-3602.
16. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
17. Josien R, Li HL, Ingulli E, Sarma S, Wong BR, et al. (2000) TRANCE, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells In Vivo. J Exp Med 191: 495-502.
18. Wong BR, Josien R, Lee SY, Sauter B, Li HL, et al. (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186: 2075-2080.
19. Bachmann MF, Wong BR, Josien R, Steinman RM, Oxenius A, et al. (1999) TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand- independent T Helper Cell Activation. J Exp Med 189: 1025-1031.
20. Kim D, Mebius RE, MacMicking JD, Jung S, Cupedo T, et al. (2000) Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 192: 1467-1478.
21. Hubert FX, Voisine C, Louvet C, Heslan JM, Ouabed A, et al. (2006) Differential pattern recognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subsets. J Immunol 177: 1007-1016.
22. Voisine C, Hubert FX, Trinite B, Heslan M, Josien R, (2002) Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity. J Immunol 169: 2284-2291.
23. Hubert FX, Voisine C, Louvet C, Heslan M, Josien R, (2004) Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG. J Immunol 172: 7485-7494.
24. Josien R, Wong BR, Li HL, Steinman RM, Choi Y, (1999) TRANCE, a TNF Family Member, Is Differentially Expressed on T Cell Subsets and Induces Cytokine Production in Dendritic Cells. J Immunol 162: 2562-2568.
25. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M, (2006) Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107: 2474-2476.
26. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, et al. (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. The Journal of biological chemistry 273: 14363-14367.
27. Chaperot L, Blum A, Manches O, Lui G, Angel J, et al. (2006) Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 176: 248-255.
28. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135: 37-48.
29. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, et al. (2006) B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. The American journal of pathology 169: 987-998.
30. Choi Y, Woo KM, Ko SH, Lee YJ, Park SJ, et al. (2001) Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. European journal of immunology 31: 2179-2188.
31. Lane PJ, Kim MY, Gaspal FM, McConnell FM, (2006) CD4+CD3- cells regulate the organization of lymphoid tissue and T-cell memory for antibody responses. International journal of hematology 83: 12-16.
32. Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, et al. (1999) Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)- converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274: 13613-13618.
33. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, et al. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
34. Avnet S, Cenni E, Perut F, Granchi D, Brandi ML, et al. (2007) Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis. International journal of oncology 30: 469-476.
35. Kramer JM, Gaffen SL, (2007) Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. Journal of periodontology 78: 1083-1093.
36. Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, et al. (2011) Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470: 548-553.
37. Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, et al. (2004) Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 10: 7466-7474.
38. Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, et al. (2005) Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. The Journal of experimental medicine 202: 425-435.
39. Kuwajima S, Sato T, Ishida K, Tada H, Tezuka H, et al. (2006) Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nature immunology 7: 740-746.